Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

被引：0
作者：
Maria Buti
Scott Fung
Edward Gane
Nezam H. Afdhal
Robert Flisiak
Selim Gurel
John F. Flaherty
Eduardo B. Martins
Leland J. Yee
Phillip Dinh
Jeffrey D. Bornstein
G. Mani Subramanian
Harry L. A. Janssen
Jacob George
Patrick Marcellin
机构：
[1] Hospital General Universitari Vall d’Hebron,Servei de Medicina Interna
[2] University of Toronto,Hepatologia
[3] Auckland City Hospital,Department of Medicine, Toronto General Hospital
[4] Beth Israel Deaconess Medical Center,Department of Gastroenterology and Hepatology
[5] Medical University of Białystok,Department of Hepatology
[6] University of Uludag,Department of Infectious Diseases and Hepatology
[7] Gilead Sciences,Department of Gastroenterology
[8] Inc.,Division of Gastroenterology
[9] Erasmus MC University Hospital,Storr Liver Unit, Westmead Millennium Institute, Westmead Hospital
[10] University of Sydney,Service d’Hépatologie, Viral Hepatitis Research Centre
[11] Hôpital Beaujon,undefined
来源：
Hepatology International | 2015年 / 9卷
关键词：
Antiviral agent; Chronic hepatitis B; Cirrhosis; Hepatitis B e antigen; Hepatitis B surface antigen; Tenofovir disoproxil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 250
页数：7
相关论文
共 166 条
[1]  
Lok AS(2002)Chronic hepatitis B N Engl J Med 346 1682-1683
[2]  
Brown A(2012)Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs Expert Rev Gastroenterol Hepatol 6 187-198
[3]  
Goodman Z(2006)Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 65-73
[4]  
Chen CJ(2006)Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 678-686
[5]  
Yang HI(2009)Chronic hepatitis B: update 2009 Hepatology 50 661-662
[6]  
Su J(2003)Histological outcome during long-term lamivudine therapy Gastroenterology 124 105-117
[7]  
Jen CL(2006)Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis b for up to 5 years Gastroenterology 131 1743-1751
[8]  
You SL(2004)Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 1521-1531
[9]  
Lu SN(2013)Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 468-475
[10]  
Huang GT(2011)Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B Gastroenterology 140 132-143
12345678910